Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
22
Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.
According to recent research from the United States, The purpose of this study was to determine if breast cancer survivors (BCS) with insomnia can be grouped according to their level of fatigue. A secondary data analysis was conducted on baseline data obtained from a randomized clinical trial that focused on a cognitive-behavioral intervention for insomnia in BCS.
Patients diagnosed with breast cancer or depression who are seeking a medical expert in their own community to guide them through treatment now have a place to start. Qforma, an advanced analytics and predictive modeling company, today introduced the new phase of its first-of-its-kind healthcare database Most Influential Doctors, or MID, presented by USA TODAY.
According to recent research published in the journal Chest, Non-small cell lung cancer (NSCLC) staging is currently being revised by the International Association for the Study of Lung Cancer (USLC). Among other changes, the revised staging system proposes the subdivision of the T1 tumor ( 2 cm but <= 3 cm).
Cancer patients don't have time to waste, yet many must endure a tedious process of elimination as physicians try several different treatments until identifying the one that is most effective against their particular type of tumor. Now researchers at the University of Virginia Health System have developed a breakthrough method that could one day eliminate this trial and error approach to treating many cancers.
According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being used to treat older women with nonmetastatic invasive breast cancer, there are still significant socioeconomic and geographic disparities in the use of this type of therapy.
According to recent research published in the journal Cancer Epidemiology Biomarkers & Prevention, Genetic predisposition to prostate cancer includes multiple common variants with a low penetrance (single nucleotide polymorphisms) and rare variants with higher penetrance. The mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2 are associated with Lynch syndrome where colon and endometrial cancers are the predominant phenotypes.
SRI International, an independent, nonprofit research and development organization, announced that it has been awarded a $1.55M U.S. Department of Defense/Prostate Cancer Research Program (DoD/PCRP) grant to support product- driven, preclinical studies of SRI's novel agents that have the potential to become prostate cancer drugs. The goal of the program is to discover treatments that can revolutionize the prevention, detection, or treatment of prostate cancer.
Clinical researchers at Princess Margaret Hospital (PMH) can now answer the question that baffles many clinicians - why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer?
The largest single-institution study of its kind has found few complications in prostate cancer patients treated with radiotherapy after surgery to remove the prostate. Men in this study received radiotherapy after a prostate-specific antigen (PSA) test following surgery indicated their cancer had recurred.
We care about your feedback. Let us know how we can improve your CancerCompass experience.